Market Research Reports- Consulting Analysis Crystal Market Research 3D Cell Culture Market | Page 2

& pharmaceutical companies, hospitals, and diagnostic centers, which further contributes to the market growth.
Besides, rise in prevalence of cancer will increase need for cancer research and development of regenerative
medicines that will drive the market during forecast period.
North America accounted for almost two-fifth of the global share of 3D cell cultures market in 2016. This is
primarily attributed to a number of factors such as large number of research laboratories, collaboration of biotech
and Pharma companies for developing advance technology, and various government initiatives to support research
and development of 3D cell culture systems in North America.
Asia-Pacific is projected to be the fastest-growing region during the forecast period, due to increase in stem cell
research in countries such as India, China, and Japan. Many key players are focusing on Asia-Pacific regions due to
low cost of operations in this region. Companies are focusing on developing technologies tailored for particular
research activity. For instance, in 2014, Japan based company, Reprocell acquired Human Tissue supplier Bioserve
for integrating pluripotent stem cell technology and 3D cell culture technology to enhance efficiency of drug testing
and cancer research.
Request a sample copy of 3D Cell Culture Market Research Report @
http://www.crystalmarketresearch.com/report-sample/HC0516
Some of the major companies include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Nano 3D
Biosciences, Promocell GmbH, Corning Inc., Biomatrix, Lonza, VWR International, LLC, Tecan Trading AG., 3D
Biotek LLC., Global Cell Solutions, Inc., and InSphero AG.
Key Findings of the Research Study:





Scaffold-based 3D cell culture segment accounted for two-fifth of the global market in 2016, due to their
unique property of adjusting biochemical and mechanical properties.
Stem-based cell culture is projected to be the fastest-growing segment over the forecast period, due to their
extensive use in tissue and organ regeneration.
Based on end-user, biotech and pharmaceutical companies segment is projected to dominate the overall
market during the forecast period, primarily due to increase in adoption of 3D cell culture by large number
of biotech and pharmaceuticals companies.
U.S. dominated the global market in 2016. Large number of research laboratories and government
initiatives supporting R&D in the field of 3D cell culture systems are set to drive the market growth during
forecast period.
Countries such as India and China will register maximum growth during forecast period due increasing use
of 3D cell culture technology, developing healthcare infrastructure, and rise in demand for regenerative
medicines developed through 3D cell culture systems to treat various diseases.
Inquire more about this report at: http://www.crystalmarketresearch.com/send-an-enquiry/HC0516
3D Cell Culture Market is Segmentation as follows: